Labarai
-
Ciwon zuciya yana buƙatar sabon magani - Vericiguat
Rashin ciwon zuciya tare da raguwar raguwar fitarwa (HFrEF) babban nau'in ciwon zuciya ne, kuma binciken HF na kasar Sin ya nuna cewa kashi 42 cikin 100 na raunin zuciya a kasar Sin HFrEF ne, ko da yake akwai nau'o'in magunguna da yawa na HFrEF kuma sun rage hadarin. na...Kara karantawa -
Magungunan da aka yi niyya don maganin myelofibrosis: Ruxolitinib
Myelofibrosis (MF) ana kiransa myelofibrosis. Haka kuma cuta ce da ba kasafai ba. Kuma ba a san dalilin da ya haifar da cutar ba. Abubuwan da aka fi sani na asibiti sune ƙananan ƙwayoyin jini na jini da ƙananan granulocytic anemia tare da yawan adadin hawaye na sauke jan jini ...Kara karantawa -
Ya kamata ku san aƙalla waɗannan maki 3 game da rivaroxaban
A matsayin sabon maganin maganin jini na baka, an yi amfani da rivaroxaban sosai a cikin rigakafi da kuma kula da cututtukan thromboembolic venous da rigakafin bugun jini a cikin fibrillation na valvular. Don amfani da rivaroxaban mafi dacewa, yakamata ku san aƙalla waɗannan maki 3….Kara karantawa -
Changzhou Pharmaceutical ya sami izini don samar da Lenalidomide Capsules
Changzhou Pharmaceutical Factory Ltd., wani reshe na Shanghai Pharmaceutical Holdings, samu da Drug Registration Certificate (Takaddar No. 2021S01077, 2021S01078, 2021S01078, 2021S01079) bayar da Jiha Drug Administration, LenaliSdompec Administration na Lenali5mgide.Kara karantawa -
Menene matakan kariya ga allunan rivaroxaban?
Rivaroxaban, a matsayin sabon maganin maganin jini na baka, an yi amfani dashi sosai a cikin rigakafi da maganin cututtuka na venous thromboembolic. Menene nake buƙatar kula da lokacin shan rivaroxaban? Ba kamar warfarin ba, rivaroxaban baya buƙatar saka idanu akan zubar jini yana nuna ...Kara karantawa -
2021 Sabbin Amintattun Magunguna na FDA 1Q-3Q
Ƙirƙira tana haifar da ci gaba. Idan ya zo ga ƙirƙira a cikin haɓaka sabbin magunguna da samfuran ilimin halitta, Cibiyar Nazarin Magunguna da Magunguna ta FDA (CDER) tana tallafawa masana'antar harhada magunguna a kowane mataki na tsari. Tare da fahimtar ta ...Kara karantawa -
Ci gaban kwanan nan na Sugammadex Sodium a cikin lokacin farkawa na maganin sa barci
Sugammadex Sodium wani sabon abokin gaba ne na zaɓaɓɓun masu shakatawa na tsoka marasa ƙarfi (myorelaxants), wanda aka fara ba da rahoto a cikin ɗan adam a cikin 2005 kuma tun daga lokacin ana amfani da shi a asibiti a Turai, Amurka da Japan. Idan aka kwatanta da magungunan anticholinesterase na gargajiya...Kara karantawa -
Wadanne ciwace-ciwace suke da tasirin thalidomide a cikin jiyya!
Thalidomide yana da tasiri wajen magance waɗannan ciwace-ciwace! 1. A cikin abin da m ciwace-ciwacen daji za a iya amfani da thalidomide. 1.1. ciwon huhu. 1.2. Prostate ciwon daji. 1.3. nodal ciwon daji. 1.4. hepatocellular carcinoma. 1.5. Ciwon daji na ciki. ...Kara karantawa -
Tofacitinib Citrate
Tofacitinib citrate magani ne na magani (sunan kasuwanci Xeljanz) wanda Pfizer ya samo asali don aji na masu hana Janus kinase (JAK). Yana iya zaɓin hana JAK kinase, toshe hanyoyin JAK/STAT, kuma ta haka ya hana watsa siginar tantanin halitta da magana mai alaƙa da alaƙa da kunnawa ...Kara karantawa -
Apixaban dan Rivaroxaban
A cikin 'yan shekarun nan, tallace-tallace na apixaban ya karu cikin sauri, kuma kasuwar duniya ta riga ta wuce rivaroxaban. Saboda Eliquis (apixaban) yana da fa'ida akan warfarin don hana bugun jini da zubar jini, kuma Xarelto (Rivaroxaban) kawai ya nuna rashin ƙarfi. Bugu da kari, Apixaban baya...Kara karantawa -
Nunin Guangzhou API a cikin 2021
Bikin baje kolin kayayyakin harhada magunguna na kasa da kasa karo na 86 na kasar Sin/Matsakaici/Marufi/Kayan aiki (API China a takaice) Mai shirya: Reed Sinopharm Nunin Co., Ltd. Lokacin nune-nunen: 26-28 ga Mayu, 2021 Wuri: China Import and Export Fair Complex (Guangzhou) Ma'aunin nuni: 60,000 murabba'in mita Ex...Kara karantawa -
Obeticolic acid
A ranar 29 ga Yuni, Intercept Pharmaceuticals ta sanar da cewa ta sami cikakken sabon aikace-aikacen magani daga FDA ta Amurka game da FXR agonist obeticholic acid (OCA) don fibrosis wanda ba ya haifar da wasiƙar amsawar steatohepatitis (NASH) ba (CRL). FDA ta bayyana a cikin CRL cewa dangane da bayanan ...Kara karantawa